Giesje Nefs

Giesje Nefs

Auto-generated profile, based on publicly available information

Giesje Nefs

Department of Medical Psychology Radboud University Medical Center Nijmegen The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2019 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
ANArie Nouwen
Arie Nouwen
MAM. C. Adriaanse
M. C. Adriaanse
KDK. van Dam
K. van Dam
MIM. M. Iversen
M. M. Iversen
WVWolfgang Viechtbauer
Wolfgang Viechtbauer
TCthe European Depression in Diabetes (EDID) Research Consortium
the European Depression in Diabetes (EDID) Research Consortium

18 August 2021 in Diabetic Medicine
Verified
Journal Article
Open access
PDF file
MBMagdalena Beran
Magdalena Beran
RMRutendo Muzambi
Rutendo Muzambi
Anouk GeraetsAnouk Geraets
Anouk Geraets
JAJuan Rafael Albertorio‐Diaz
Juan Rafael Albertorio‐Diaz
MAMarcel C. Adriaanse
Marcel C. Adriaanse
FCfor the European Depression in Diabetes (EDID) Research Consortium
for the European Depression in Diabetes (EDID) Research Consortium
Aim: To investigate whether there is a bidirectional longitudinal association of depression with HbA1c.Methods: We conducted a systematic literature search in PubMed, PsycINFO, CINAHL and EMBASE for observational, longitudinal studies published from January 2000 to September 2020, assessing the association between depression and HbA1c in adults. We assessed study quality with the Newcastle‐Ottawa‐Scale. Pooled effect estimates were reported as partial correlation coefficients (rp) or odds ratios (OR).Results: We retrieved 1642 studies; 26 studies were included in the systematic review and eleven in the meta‐analysis. Most studies (16/26) focused on type 2 diabetes. Study quality was rated as good (n = 19), fair (n = 2) and poor (n = 5). Of the meta‐analysed studies, six investigated the longitudinal association between self‐reported depressive symptoms and HbA1c and five the reverse longitudinal association, with a combined sample size of n = 48,793 and a mean follow‐up of 2 years. Higher levels of baseline depressive symptoms were associated with subsequent higher levels of HbA1c (partial r = 0.07; [95% CI 0.03, 0.12]; I238%). Higher baseline HbA1c values were also associated with 18% increased risk of (probable) depression (OR = 1.18; [95% CI 1.12,1.25]; I20.0%).Conclusions: Our findings support a bidirectional longitudinal association between depressive symptoms and HbA1c. However, the observed effect sizes were small and future research in large‐scale longitudinal studies is needed to confirm this association. Future studies should investigate the role of type of diabetes and depression, diabetes distress and diabetes self‐management behaviours. Our results may have clinical implications, as depressive symptoms and HbA1c levels could be targeted concurrently in the prevention and treatment of diabetes and depression.Registration: PROSPERO ID CRD42019147551.

1 June 2021 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
NLNanna Lindekilde
Nanna Lindekilde
FRFemke Rutters
Femke Rutters
JHJan Erik Henriksen
Jan Erik Henriksen
MLMathias Lasgaard
Mathias Lasgaard
MSMiranda T. Schram
Miranda T. Schram
FPFrans Pouwer
Frans Pouwer
Having a psychiatric disorder may increase the risk of developing type 2 diabetes[T2D] and this umbrella review aims to determine whether people with a psychiatric disorder have an increased risk of developing T2D and to investigate potential underlying mechanisms. A literature search was performed to identify systematic reviews of longitudinal studies investigating different psychiatric disorders as risk factors for incident T2D in humans (≥18 years). A total of 8,612 abstracts were identified, 180 full-text articles were read, and 25 systematic reviews were included. Six categories of psychiatric disorders were identified. Except for eating disorders, all psychiatric disorders were associated with increased risk of incident T2D ranging from RR = 1.18 [95% CI 1.12-1.24] to RR = 1.60 [95% CI 1.37-1.88] for depression; from RR = 1.27 [95% CI 1.19-1.35] to OR = 1.50 [95% CI 1.08-2.10] for use of antidepressant medication; from OR = 1.93 [1.37-2.73] to OR = 1.94 [1.34-2.80] for use of antipsychotic medication; from RR = 1.55 [95% CI 1.21-1.99] to RR = 1.74 [95% CI 1.30-2.34] for insomnia, and finally showed OR = 1.47 [95% CI 1.23-1.75] for anxiety disorders. Plausible underlying mechanisms were discussed, but in most reviews corrections for mechanisms did not explain the association. Notable, only 16% of the systematic reviews had a high methodological quality.

1 September 2015 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
GNGiesje Nefs
Giesje Nefs
EDEsther Donga
Esther Donga
ESEus van Someren
Eus van Someren
MBMariska Bot
Mariska Bot
JSJane Speight
Jane Speight
FPFrançois Pouwer
François Pouwer

1 April 2015 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
GNG. Nefs
G. Nefs
JSJane Speight
Jane Speight
FPF. Pouwer
F. Pouwer
VPV. Pop
V. Pop
MBM. Bot
M. Bot
JDJ. Denollet
J. Denollet

1 August 2019 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
GNGiesje Nefs
Giesje Nefs
CHChristel Hendrieckx
Christel Hendrieckx
PRPrasuna Reddy
Prasuna Reddy
JBJessica L. Browne
Jessica L. Browne
MBMariska Bot
Mariska Bot
FPFrançois Pouwer
François Pouwer